Brief: Angelini Pharma To Buy Catalyst Pharmaceuticals For $4.1 Bln
07/05/2026 14:05
May 7 (Reuters) - Catalyst Pharmaceuticals Inc CPRX.O: ANGELINI PHARMA TO ACQUIRE CATALYST PHARMACEUTICALS FOR 4.1 BILLION USD (3.5 BILLION EUROS), ENTERING THE U.S. MARKET AND CONSOLIDATING ITS LEADERSHIP IN BRAIN HEALTH AND RARE DISEASE ANGELINI PHARMA TO BUY CATALYST PHARMACEUTICALS FOR $31.50 PER SHARE IN $4.1 BILLION DEAL DEAL EXPECTED TO CLOSE IN Q3 2026 DEAL TO BE CARRIED OUT WITH PARTICIPATION OF BLACKSTONE FUNDS AND SELECT INTERNATIONAL PARTNERS Further company coverage: CPRX.O ((Reuters.Briefs@thomsonreuters.com;))